Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ECYT
Delisted

Endocyte Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Jan 18, 2019

Range Low Price High Price Comment
30 days $23.97 $24.00 Friday, 18th Jan 2019 ECYT stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $23.37 $24.00
52 weeks $2.81 $24.00

Historical Endocyte prices

Date Open High Low Close Volume
Jun 14, 2018 $14.47 $14.88 $14.14 $14.44 870 928
Jun 13, 2018 $14.69 $14.84 $13.75 $14.40 1 218 783
Jun 12, 2018 $14.24 $15.45 $14.17 $14.69 1 835 429
Jun 11, 2018 $13.75 $14.99 $13.75 $14.22 2 192 372
Jun 08, 2018 $12.81 $13.70 $12.67 $13.65 928 312
Jun 07, 2018 $12.67 $12.95 $12.38 $12.92 762 392
Jun 06, 2018 $12.72 $13.04 $12.46 $12.61 1 079 529
Jun 05, 2018 $13.32 $13.68 $12.55 $12.82 1 217 740
Jun 04, 2018 $13.61 $13.99 $12.53 $13.30 1 645 127
Jun 01, 2018 $13.79 $13.99 $13.22 $13.50 1 028 838
May 31, 2018 $14.31 $14.45 $13.33 $13.67 1 594 963
May 30, 2018 $14.00 $14.56 $14.00 $14.30 986 048
May 29, 2018 $13.33 $14.24 $13.19 $13.98 1 313 671
May 25, 2018 $13.97 $14.00 $12.72 $13.33 1 629 214
May 24, 2018 $14.09 $14.28 $13.90 $14.06 883 581
May 23, 2018 $14.26 $14.59 $13.85 $14.01 1 239 925
May 22, 2018 $14.54 $14.85 $14.20 $14.40 975 065
May 21, 2018 $14.59 $14.73 $13.91 $14.29 1 162 956
May 18, 2018 $13.96 $14.55 $13.51 $14.45 2 300 009
May 17, 2018 $13.85 $14.86 $13.32 $13.51 3 306 813
May 16, 2018 $12.15 $13.18 $12.12 $12.56 2 172 022
May 15, 2018 $11.78 $12.22 $11.48 $12.11 863 705
May 14, 2018 $12.35 $12.35 $11.63 $11.81 741 078
May 11, 2018 $11.80 $12.22 $11.80 $12.21 1 139 226
May 10, 2018 $12.18 $12.48 $11.65 $11.72 1 057 913
Click to get the best stock tips daily for free!

About Endocyte

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trials to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of ad... ECYT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT